Cyclophosphamide in Patients with Systemic Sclerosis–associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis
H Barnes, M Ghazipura, D Herman… - Annals of the …, 2024 - atsjournals.org
Background: The American Thoracic Society convened an international, multidisciplinary
panel to develop clinical practice guidelines for the treatment of systemic sclerosis …
panel to develop clinical practice guidelines for the treatment of systemic sclerosis …
Tocilizumab in Patients with Systemic Sclerosis–associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis
M Ghazipura, M Macrea, D Herman… - Annals of the …, 2024 - atsjournals.org
Background: The American Thoracic Society (ATS) convened an international,
multidisciplinary panel to develop clinical practice guidelines for the treatment of systemic …
multidisciplinary panel to develop clinical practice guidelines for the treatment of systemic …
Treatment of systemic sclerosis–associated interstitial lung disease: evidence-based recommendations. An official American Thoracic Society clinical practice …
G Raghu, SB Montesi, RM Silver, T Hossain… - American journal of …, 2024 - atsjournals.org
Background: Interstitial lung disease (ILD) is a significant cause of morbidity and mortality in
patients with systemic sclerosis (SSc). To date, clinical practice guidelines regarding …
patients with systemic sclerosis (SSc). To date, clinical practice guidelines regarding …
Mycophenolate in Patients with Systemic Sclerosis–associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis
D Herman, M Ghazipura, H Barnes… - Annals of the …, 2024 - atsjournals.org
Rationale: The American Thoracic Society convened an international, multidisciplinary
panel to develop clinical practice guidelines for the treatment of systemic sclerosis …
panel to develop clinical practice guidelines for the treatment of systemic sclerosis …
[PDF][PDF] Treatment of SSc–associated ILD: Evidence-based Recommendations An Official ATS Clinical Practice
G Raghu - Am J Respir Crit Care Med [online …, 2023 - medinfo.boehringer-ingelheim.com
Background: Interstitial lung disease (ILD) is a significant cause of morbidity and mortality in
patients with systemic sclerosis (SSc). To date, clinical practice guidelines regarding …
patients with systemic sclerosis (SSc). To date, clinical practice guidelines regarding …
[PDF][PDF] Treatment of Systemic Sclerosis–associated Interstitial Lung Disease: Evidence-based Recommendations
G Raghu, SB Montesi… - Am J Respir Crit …, 2023 - avancesenfibrosispulmonar.com
Background: Interstitial lung disease (ILD) is a significant cause of morbidity and mortality in
patients with systemic sclerosis (SSc). To date, clinical practice guidelines regarding …
patients with systemic sclerosis (SSc). To date, clinical practice guidelines regarding …
Advances in the Understanding, Diagnosis, and Treatment of Systemic Sclerosis A Comprehensive Review of Recent Developments
I Moreau, M Kulak, K Sokołowska, D Bereza… - Journal of Education …, 2024 - apcz.umk.pl
Systemic sclerosis (SSc) is a multifaceted autoimmune disorder characterized by
widespread organ involvement, impacting the skin, lungs, gastrointestinal tract, and blood …
widespread organ involvement, impacting the skin, lungs, gastrointestinal tract, and blood …